Neuracle places first commercial NEO implant at Huashan Hospital
NEO received Chinese regulatory approval in March as the first invasive BCI cleared for commercial use by any national regulator.
The full briefing is in the app.
NEO received Chinese regulatory approval in March as the first invasive BCI cleared for commercial use by any national regulator.
The full briefing is in the app.